IMEXHS Limited (IME)

Location:: Melbourne, Australia
Market Cap:: $20 million
Sector:: Health Care
Website:: http://www.imexhs.com.au

Share Price & Volume

Latest Open Briefings

01 Sep 2023
IMEXHS HY23 Results Presentation
01 Mar 2023
IMEXHS FY22 Results Presentation
30 Aug 2022
IMEXHS Limited 1H FY22 Conference Call
01 Mar 2022
IMEXHS Limited FY21 Conference Call
30 Aug 2021
IMEXHS Limited 1H FY21 Conference Call

Load next 5 items

Latest Market Announcements

17:30 23 Dec
Appendix 3Y - Damian Banks
17:30 23 Dec
Appendix 3Y - Douglas Flynn
17:20 23 Dec
Application for quotation of securities - IME
12:58 23 Dec
Notification of cessation of securities - IME
09:40 17 Nov
CEO Options in lieu of Salary

Load next 5 items

ASX Announcements delayed by 20 minutes.

You may also be interested in...

View all

Other Open Briefings in the Health Care Sector

20 Nov 2025
AFT Pharmaceuticals - ASX Listing (AFP)
FY2026 Half Year Results Analyst Briefing
25 Aug 2025
Ansell Limited (ANN)
Ansell FY25 Full Year Results Briefing
22 Aug 2025
Monash IVF Group Limited (MVF)
Monash IVF Group Limited FY25 Full Year Results announcement
21 Aug 2025
Healius Limited (HLS)
Healius FY25 Results
01 Aug 2025
AFT Pharmaceuticals - ASX Listing (AFP)
AFT Pharmaceuticals 2025 Annual General Meeting
22 May 2025
AFT Pharmaceuticals - ASX Listing (AFP)
FY2025 Full Year Results Analyst Briefing
27 Mar 2025
Healius Limited (HLS)
Healius Investor Day
27 Feb 2025
Monash IVF Group Limited (MVF)
Monash IVF Group Limited FY25 Half Year Results announcement
20 Feb 2025
Healius Limited (HLS)
Healius 1H25 Results
21 Nov 2024
AFT Pharmaceuticals - ASX Listing (AFP)
FY2025 Half Year Results Analyst Briefing

About Us

Open Briefing is an online investor communication platform that provides ASX listed companies with a dedicated site for hosting, distributing and archiving important market updates and provides investors with a central resource for increasing their understanding of a company's fundamentals and strategic direction. Read more

Stay Informed

Subscribe to receive the latest Open Briefings